Financial Analysis: Nature’s Sunshine Products (NASDAQ:NATR) and PhaseBio Pharmaceuticals (NASDAQ:PHAS)
Nature’s Sunshine Products (NASDAQ:NATR) and PhaseBio Pharmaceuticals (NASDAQ:PHAS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.
Institutional and Insider Ownership
75.7% of Nature’s Sunshine Products shares are held by institutional investors. Comparatively, 65.7% of PhaseBio Pharmaceuticals shares are held by institutional investors. 20.3% of Nature’s Sunshine Products shares are held by insiders. Comparatively, 17.0% of PhaseBio Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Nature’s Sunshine Products and PhaseBio Pharmaceuticals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Nature’s Sunshine Products||0.82%||4.83%||2.93%|
This is a summary of current ratings and target prices for Nature’s Sunshine Products and PhaseBio Pharmaceuticals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Nature’s Sunshine Products||0||0||0||0||N/A|
PhaseBio Pharmaceuticals has a consensus price target of $20.67, indicating a potential upside of 335.09%. Given PhaseBio Pharmaceuticals’ higher probable upside, analysts plainly believe PhaseBio Pharmaceuticals is more favorable than Nature’s Sunshine Products.
Earnings & Valuation
This table compares Nature’s Sunshine Products and PhaseBio Pharmaceuticals’ top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Nature’s Sunshine Products||$364.81 million||0.50||-$850,000.00||N/A||N/A|
|PhaseBio Pharmaceuticals||$670,000.00||203.47||-$23.85 million||($4.49)||-1.06|
Nature’s Sunshine Products has higher revenue and earnings than PhaseBio Pharmaceuticals.
Nature’s Sunshine Products beats PhaseBio Pharmaceuticals on 8 of the 11 factors compared between the two stocks.
About Nature’s Sunshine Products
Nature's Sunshine Products, Inc., a natural health and wellness company, primarily engages in the manufacture and sale of nutritional and personal care products worldwide. It operates through four segments: NSP Americas; NSP Russia; Central and Eastern Europe; and NSP China. The company offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, including oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpastes, and skin cleansers, as well as weight management products. The company offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent managers and distributors. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
About PhaseBio Pharmaceuticals
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat orphan diseases with an initial focus on cardiopulmonary indications. Its lead product candidate, PB2452, is a reversal agent for the antiplatelet drug ticagrelor that has completed a Phase 1 clinical trial and is been developed for the treatment of patients on ticagrelor who are experiencing a major bleeding event or those who require urgent surgery. It is also developing PB1046, a fusion protein currently in a Phase 2b clinical trial for the treatment of pulmonary arterial hypertension. The company was founded in 2002 and is based in Malvern, Pennsylvania.
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.